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Carcinogen exposure from tobacco smoking is the major cause of upper aerodigestive tract cancer, yet heavy smokers only have
about a 10% life-time risk of developing one of these cancers. Current technologies allow only limited prediction of cancer risk and
there are no approved screening methods applicable to the general population. We developed a method to assess somatic
mutational load using small-pool PCR (SP-PCR) and analysed mutations in DNA isolated from cells obtained by mouth rinse.
Mutation levels in the hypermutable tetranucleotide marker D7S1482 were analysed in specimens from 25 head and neck squamous
carcinoma (HNSCC) cases and 31 controls and tested for associations with age, smoking history and cancer status. We found a
significant association between mutation frequency and age (P¼0.021, Generalized Linear Model (GLM), N¼56), but no influence
of smoking history. Cases had higher mutation frequencies than controls when corrected for the effects of age, a difference that was
statistically significant in the subgroup of 10 HNSCC patients who were treated with surgery only (P¼0.017, GLM, N¼41). We also
present evidence that cancer status is linked to levels of nonunique, and presumably clonally derived, mutations in D7S1482. Insertion
mutations were observed in 833 (79%) of 1058 alleles, of which 457 (43%) could be explained by insertion of a single repeat unit;
deletion mutations were found in 225 (21%) of tested alleles. In conclusion, we demonstrate that the sensitive detection of single
molecule mutations in clinical specimens is feasible by SP-PCR. Our study confirms an earlier report that microsatellite mutations
increase with age and is the first to provide evidence that these mutations may be associated with cancer status in individual subjects.
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It is estimated that exposure to tobacco carcinogens causes up to
90% of respiratory tract cancers (ACS, 2003), yet the risk of
developing a tobacco-related cancer in a lifetime smoker is less
than 10%. Currently, the only useful measures to predict an
individual’s risk for developing lung or head and neck cancer are
based on exposure, age of the individual and, if detectable, the
presence of premalignant lesions. Given the significant role of
carcinogen exposure in these tumours, it proves difficult to study
host factors related to cancer risk (Proia et al, 2006). Such studies
are based on measurement of host DNA repair capacity, such as
the bleomycin chromosome breakage assay (Wu et al, 1998;
Rajaee-Behbahani et al, 2001), the host-cell reactivation assay
(Diem and Runger, 1997), or the comet assay (Kleinsasser
et al, 2000). These assays suggest host impairments in DNA
repair, but they have found limited application in the clinical
setting because they require intact cells, are labour intensive and
may have limitations with respect to reproducibility (Berwick and
Vineis, 2000).
Mutations in microsatellites provide an alternative and more
direct avenue to determine susceptibility to DNA damage. The
benefit of such an approach lies in the possibility that differences
in carcinogen metabolism may more accurately predict cancer
risk. Microsatellites consist of repetitive DNA sequences (Weber,
1990) that can pose difficulties for cellular DNA replication and
repair mechanisms (Gordenin and Resnick, 1998). In cells with
intact MMR, microsatellite repeat sequences are sensitive to
mutagen-induced mutations, first shown in an Escherichia coli
model system (Jackson et al, 1998). Low levels of microsatellite
mutations have been observed in tumours with no known
mutations in mismatch repair genes, such as those of the lung,
bladder, and head and neck (Mao et al, 1994; Shridhar et al, 1994;
Woenckhaus et al, 2003). Mutations in lung cancer are more
frequently found in tetranucleotide repeats than in dinucleotide
repeats (Spafford et al, 2001; Xu et al, 2001), a phenomenon called
Elevated Microsatellite Alterations at Selected Tetranucleotide
repeats (EMAST). The underlying mechanism for EMAST is
not known, but it is possible that mechanisms other than MMR
gene deficiency contribute to the mutations in these tumours,
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sespecially in selected microsatellites with AAAG or ATAG
repeat units (Ahrendt et al, 2000; Spafford et al, 2001; Xu et al,
2001). In one study, the occurrence of (AAAG)n mutations was
associated with mutations in the p53 tumour suppressor gene
(Ahrendt et al, 2000).
In human lung or head and neck tumours, microsatellite
mutations might reflect the high mutational load experienced by
the epithelial lining of the respiratory tract exposed to tobacco
smoke. We previously demonstrated that microsatellite repeat
sequences are more sensitive to mutagens than nonrepeated
sequences, leading to frameshifts in a reporter construct (Slebos
et al, 2002), while a study of primary lung tumours in patients who
had undergone previous radiation and/or chemotherapy treatment
for Hodgkin lymphoma showed increased levels of microsatellite
mutations (Behrens et al, 2000). Some tetranucleotide repeats also
demonstrate high levels of instability in the germline (Ellegren,
2000). Results from these studies suggest that microsatellites are
highly mutable, making them an attractive target for study, and
that tetranucleotide repeats may be particularly sensitive to DNA
damage. Technical advances have resulted in high-throughput
methodology that allowed us to study microsatellite mutations at
the single molecule level in clinical specimens (Coolbaugh-Murphy
et al, 2004).
Mutation measurements are complicated by a process called ‘field
cancerisation’, by which carcinogen exposure of a larger field of cells
(e.g. oral or bronchial epithelium) leads to groups of related, but
histologically normal, cells that spread to cover a large epithelial
surface (Slaughter et al, 1953). We, and others, showed that such
premalignant groups of cells can carry distinct genetic alterations
that are identical to those found in overt cancers (Sozzi et al, 1995;
Westra et al, 1996; Mao et al, 1997; Tabor et al, 2001). In our study,
field cancerisation may lead to an apparent increase in the mutation
measurement due to selective outgrowth of an otherwise normal cell
clone carrying a mutant microsatellite sequence.
We here describe a study of mutations in the tetranucleotide
marker D7S1482 in cells obtained by mouth rinse in a case–
control study for head and neck cancer. We report a strong
correlation between microsatellite mutations and age, but not with
smoking history, and that cancer cases have higher age-controlled
mutation levels than controls, suggesting that microsatellite
mutations may be useful as markers for cancer risk.
METHODS
Clinical specimens and sample processing
All specimens were obtained from the Head and Neck Tissue
Repository at Vanderbilt University with subjects consenting
according to IRB-approved protocols. Cases were identified by
searching all incident HNSCC patients seen at Vanderbilt between
2003 and 2006 who had completed curative treatment and who had
a mouth rinse collected during a follow-up visit and no evidence of
disease based on clinical exam at time or collection or during the
follow-up period (median follow-up time 29 months, range 6–40
months). Control subjects were recruited during screening days for
head and neck cancer organised through the Yul Brynner
Foundation during 2004 and 2005 (www.headandneck.org). None
of the control subjects had any symptoms of HNSCC on clinical
exam. An effort was made to cover the full range for age and
smoking histories, and to match cases and controls based on these
parameters. In the final study set, the median age difference
between cases and matched controls was 0 years (range: 13–14
years) with 19 of 25 pairs matched within 5 years of age. Matching
by sex and by smoking history (ever vs never) was successful for 20
of 25 case–control pairs each.
Subjects donated a blood specimen, a mouth rinse and answered
a simple questionnaire on demographic, clinical and exposure
information. Mouth rinse was collected using an over-the-counter
mouth wash and kept at 41C until processing. The cells were
collected by centrifugation at 1200g and DNA was isolated using
the Gentra Puregene buccal cell kit (Qiagen, Valencia, CA, USA).
Germline allele sizes were tested in blood lymphocyte DNAs and
found to be in accordance with the most frequently observed allele
sizes in all buccal cell DNAs.
Analysis of microsatellite mutations
Microsatellite mutations were detected similarly to the method
described by Coolbaugh-Murphy et al (Coolbaugh-Murphy et al,
2004), with the main difference of using a single amplification
reaction using time-release PCR (Slebos et al, 2004b). To
determine the appropriate dilution levels we ran test amplifications
with 10-fold dilution series on all DNAs. Traditional DNA
quantitation was of limited value for this purpose presumably
because of varying levels of nonhuman DNA in the mouth rinse
samples. A wide variation in DNA concentration was observed
between different preparations from cells obtained by mouth rinse,
with optimal dilutions ranging from 8 to 50000-fold of the initial
DNA preparation. Experiments that had on average more than four
molecules per well in a 96-well plate, as determined by counting
blank wells and Poisson modeling (see statistical analysis below),
were excluded to retain sensitivity to detect mutant sequences.
To assess variability of ‘small-pool’ PCR (SP-PCR) measure-
ments we analysed duplicate D7S1482 measurements on identical
DNA preparations from 23 of the subjects described in this study
(Supplementary Table 1). We formally tested for differences
between first and second replicate analysis using the Poisson-
based GLM and this test demonstrated no significant difference in
number and type of mutations between the measurements.
Microsatellite marker analyses
We report mutation analysis results obtained with the tetranucleo-
tide microsatellite marker D7S1482, which is a hypermutable
marker in both germline and somatic cells (Temam et al, 2003;
Slebos et al, 2004a). DNAs obtained from mouth rinses was diluted
to near-single molecule levels and amplified using time-release
PCR (Kebelmann-Betzing et al, 1998; Slebos et al, 2004b). The
resulting SP-PCR reflects the amplification of small numbers of
molecules that can be separated by automated capillary gel
electrophoresis as reported by others (Coolbaugh-Murphy et al,
2005). Details of the method have been described previously
(Slebos et al, 2004b). The optimal dilution for each DNA was
determined by testing serial dilutions of a small number of tubes
and estimating DNA concentration as described under statistical
analysis below. In addition to D7S1482, we also used markers
MycL1 and DXS981 to more accurately determine DNA quantity
for single-molecule analysis.
Mutations were scored according to the following criteria.
Insertion mutations were scored when peaks of at least 20% the
height of the wild-type peak closest to the presumed mutant peak
was observed in a position that indicated increased fragment
length and that did not correspond to the peaks observed in
undiluted DNAs obtained from blood lymphocytes of the same
subject (for example Figure 1C, third panel). Similarly, deletion
mutations were scored as peaks of at least 50% of the height of the
nearest wild-type peak in the spectrum indicating decreased
fragment length compared to the germline pattern (for example
Figure 1A, middle panel). These criteria are conservative since
germline allelic patterns judged according to these criteria never
resulted in a mutant score. Mutations were assumed to originate
from the germline fragment size closest to the one observed for
the aberrant signal. Aberrant signals in positions more than three
repeat units away and signals equidistant to either germline
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sfragment sizes were scored as ‘other’ mutations (Figure 1B bottom
panel and 1C 4th panel).
Statistical analysis of microsatellite data
We studied the association between mutant frequency of D7S1482
and the a-priori defined parameters of age, smoking status and
case–control status. With the assumptions that the event of
observing a mutant allele is independent between subjects and the
rate of mutation is constant over time, the number of mutant
observed has a Poisson distribution given by PðY ¼ yÞ¼my  
e  m ðÞ =y! where y is the number of mutant alleles observed and m is
the expected count of mutant alleles and this expected value, m,i s
the product of the mutant frequency and the total number of
alleles. A Generalised Linear Model (GLM), Poisson Regression,
can be adopted to model the effects of the above clinical
parameters on microsatellite mutation frequency. However, it is
not appropriate to compare the expected number of mutant alleles
when the total number of alleles at risk may differ for each subject
in different treatment groups. Therefore, the Poisson model will
include an offset equal to the log of the total number of alleles
tested and model the mutation frequency that can be compared
between subjects in different groups.
Applying a GLM would be straightforward if we have the data
with the number of mutant and the total number of alleles at risk
for mutation. However, it was not possible to count the total
number of alleles directly from each experiment and this value
needs to be estimated. This was accomplished by estimating the
average number of alleles per well in a 96-well plate, since the total
number of alleles is the product of the average number of alleles
per well and the number of wells (fixed). We derived the average
number of alleles per well from the 96-well plate by recording the
number of nonamplifying wells (blank wells) for either D7S1482 or
a combination of D7S1482, DXS981 and MycL1. The number of
blank wells from a total 96 wells follows a binomial distribution
with a ‘success’ probability p that is the probability of zero alleles
observed in the well. The count of alleles also has a Poisson
distribution with PðX ¼ kÞ¼l
k   e  l ðÞ =k!, where k is the observed
number of alleles per well, l is the expected (average) number of
alleles per well. Obviously, we have the ‘success’ probability p from
the binomial distribution that equals the Poisson probability for k
equals 0, that is, p ¼ PðX ¼ 0Þ¼e l. Since the marker measure-
ments are independent, we can get the likelihood function that is
the product of binomial mass function for the marker(s), and this
function can be expressed in terms of l. The maximum likelihood
estimator MLE of l can then be obtained by maximising this
likelihood function. After estimating the average number of alleles
per well, the total number of alleles can be calculated as
the product of this maximum likelihood estimator of l and the
number of wells. In this calculation of l, we take into account
the differences between males and females in copy numbers of the
X-chromosome linked marker DXS98 and markers MycL1/
D7S1482/DXS981 exist in a 2:2:1 ratio in males and in a 1:1:1
ratio in females. With the estimated total number of alleles and the
number of mutant observed, we applied the GLM to examine the
effects of age, smoking and case status on mutation frequencies.
We considered significance at the 0.05 level.
RESULTS
Study subjects and demographic information
A total of 56 subjects (25 cases and 31 controls) were studied for
D7S1482 microsatellite mutations in cells from oral rinses
(Table 1). The age distribution and smoking histories of cases
and controls was very similar although there were proportionally
more females in the control group than in the case group. Since
394 nt 410 nt 374 nt 378 nt 372 nt 378 nt
Figure 1 Example of microsatellite analysis. DNA from cells obtained by mouth rinse from three subjects were analysed by SP-PCR using the marker
D7S1482 (A–C). Each subpanel represents the results from one PCR tube with 5 subpanels shown for each subject. The normal (nonmutated) fragment
length is indicated by the dotted line, mutant DNA fragments are indicated by arrows.
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ssamples from cases were obtained after cancer treatment, DNA
damage due to therapy with radiation or chemotherapeutic drugs
is a potential confounder favoring higher mutation measurements
in cases compared to controls. On the other hand, cancer
treatment may selectively eliminate abnormal cells that might be
mutant for D7S1482, which would have the opposite effect on
mutation frequency measurements. Confounding by treatment is
taken into account in the statistical analyses by including these
treatments in the model and by a separate analysis with the 10
patients who were not treated by chemotherapy and/or radiation
therapy (eight oral cavity and two larynx carcinoma patients).
Types of mutations as study end points
The primary end point was D7S1482 mutation frequency, defined
as the summation of all mutations observed in D7S1482 divided by
the total number of alleles tested. Such mutations can be explained
by at least two mechanisms: (1) independent mutational events
occurring in individual cells; and (2) linked mutational events
arising from clonal outgrowth of a single cell containing the
microsatellite mutation. We presume that at least a subset of
mutations observed more than once in a single specimen are not
independent in origin, which violates the assumption of indepen-
dence in the statistical model. One solution to this problem is to
ignore any mutations that occur two or more times and scoring
only the number of mutant positions that are observed in a given
sample. We will call this secondary end point ‘unique mutations’.
This measure is less sensitive than overall mutation frequency
since some mutations detected more than once may be the result of
independent events rather than clonal outgrowth, but using this
end point assures that the observed unique mutations are truly
derived from independent events. On the other hand, mutant
alleles arising from clonal outgrowth of normal mucosal cells are of
interest in upper aerodigestive tract cancers, since these potentially
clonal mutations may represent a measure of field cancerisation.
Any mutant allele that is observed more than once may result from
an identical independent mutational event or from clonal out-
growth of a ‘cancerised’ normal mucosal cell. Since we cannot
distinguish between these two possibilities we will define these
potentially clonal mutations as ‘nonunique mutations’. In a setting
where a single allele-size is observed multiple times, nonunique
mutation frequency is expected to capture at least a proportion of
mutations from a clonal outgrowth of normal mucosal cells.
Microsatellite mutations, age and smoking
Based on a previous study on microsatellite mutations in blood
lymphocyte DNA (Coolbaugh-Murphy et al, 2005), we performed a
univariate analysis of the association of microsatellite mutations
with age in the control group. As shown in Figure 2, univariate
analysis showed a statistically significant increase of D7S1482
mutation frequency with increasing age (P¼0.004, GLM).
Although there was a clear trend towards increasing mutation
frequency with increasing age, substantial individual differences
were also observed. Since cells obtained by mouth rinse are
potentially exposed to carcinogens from tobacco smoke, we next
included smoking in the model, either as pack-year (PY, number of
packs per day multiplied by number of years smoked) or
categorised as never, former or current smoker. These compar-
isons did not demonstrate any effect of smoking although the
effect of aging remained significant. Similarly, there were no
differences in direct comparisons between the three classes of
smokers (never vs ever, never vs current, never vs former or former
vs current).
Cancer status and microsatellite mutations
Differences in D7S1482 mutation levels between HNSCC cases and
controls were tested by a generalised linear model (GLM), Poisson
regression model, including all cases and controls with age, pack-
year and case status as covariates. In this model, only the effect of
Table 1 Characteristics of study subjects
Cases
(N¼25)
Controls
(N¼31)
Total
(N¼56)
Age (median, range) 54 (31–73) 51 (36–82) 53 (31–82)
Sex
Male 19 14 33
Female 6 17 23
Race
White 22 30 52
Black 3 0 3
Other 0 1 1
Tobacco use
Never 3 10 13
Former 6 11 17
Current 16 10 26
Alcohol abuse
a
Yes 4 2 6
No 21 29 50
Tumour site
Oral cavity 10 N/A N/A
Oropharynx 4
Larynx 10
Hypopharynx 1
Treatment modalities
Radiation therapy only 5 N/A N/A
Chemotherapy only 1
Radiation and
chemotherapy
9
Surgery only 10
aDefined as more than three glasses per day.
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Figure 2 Observed and expected mutation frequency and age. Indicated
are the observed D7S1482 mutation frequencies with 95% CI for all 31
control subjects. Mutation frequency increases with increasing age
(P¼0.004, GLM) as indicated by the predicted estimate from the
univariate statistical model (solid line).
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sage was significant (P¼0.021, GLM), whereas cases had higher
mutation levels but this did not reach statistical significance
(P¼0.104, GLM) (Table 2). For example, the rate ratio per 10-year
increase in age is about 1.34 with 95% confidence interval
1.05–1.70, indicating that the increase in mutation rate per 10-
year interval is about one third. When all subjects are considered,
the rate ratio for HNSCC cases vs controls is 1.61 (95% CI 0.91–
2.82). However, the analysis of all patients in the study is
complicated by the fact that 15 of the 25 cases either received
radiation and/or chemotherapy prior to collection of the mouth
rinse specimens. We therefore limited our analysis to the 10 cases
treated with surgery only and compared these to the full control
group. In this analysis, the effect of age was borderline significant
(P¼0.067, GLM), while cases had significantly higher levels of
D7S1482 mutations than controls (P¼0.017, GLM). In this
comparison, surgery-only HNSCC cases had on average twofold
higher mutation frequencies than controls (95% CI 1.17–3.67)
(Table 2).
Unique and nonunique microsatellite mutations
When we tested unique mutations as end point, the effects of aging
remained strong but again, no apparent effect of smoking could be
discerned. In the control group, the GLM including age and
smoking, age was significantly correlated with increasing unique
mutations (P¼0.036, GLM). As with overall mutations, neither PY
nor smoking status had any significant effect in this model. Next,
we tested the effect of cancer status in a model that included age,
smoking and case–control status using unique mutations in
D7S1482 as end point. In this comparison, age remained highly
significant (P¼0.002, GLM), but smoking (as PY or by category)
or case status did not show any effect (Table 2). A similar result
was obtained when the 10 surgery-only cases were used in this
comparison.
As previously discussed, levels of nonunique microsatellite
mutations in cells obtained by mouth rinse may indicate clonal
outgrowth of normal mucosal cells and hence be a measure of field
cancerisation within the oral cavity. Using nonunique mutations as
end point, we tested for the effect of aging and smoking using the
control group only (Table 2). Levels of nonunique mutations again
increased with age (P¼0.035, GLM) but not with pack-year
(P¼0.443, GLM). We then tested for increases associated with case
status in a model including all cases and controls using D7S1482 as
end point (Table 2). In this model, the increase in mutations with
age was statistically significant (P¼0.045, GLM) but smoking
again did not show any significant difference. Case status was
borderline significantly associated with higher nonunique muta-
tion levels (P¼0.091, GLM) but in the comparison with the 10
surgery-only patients an increase in nonunique mutations was
statistically significant (P¼0.012, GLM).
Mutation patterns in D7S1482
Mutations in D7S1482 were scored according to the minimal
frame-shift that would explain the observed mutant alleles. We
observed a total of 1058 mutant alleles across all subjects studied.
The majority of these mutant alleles were insertion mutations: 833
(79%) of 1058 alleles were larger than the size of the corresponding
germline allele, of which 457 (43%) could be explained by the
insertion of one repeat unit (four nucleotides) 176 (17%) by two
repeat units, 66 (6%) by three repeat units and the remaining 134
(13%) by four or more repeat units or by undetermined repeat-
unit shifts. Deletion mutations were much less often observed, 225
alleles were smaller than their corresponding germline alleles. The
type of mutations in D7S1482 did not appear to be different
between HNSCC cases and controls (Figure 3) although cases had a
Table 2 Multivariate analysis of overall, unique and nonunique mutations in D7S1482
Surgery only/controls (N¼41) Controls only (N¼31) All subjects (N¼56)
Overall mutations
Age
a 1.267, (0.991–1.618); 0.067 1.343 (1.117–1.614); 0.004 1.340 (1.054–1.702); 0.021
Pack-year
b 0.968 (0.969–1.079); 0.561 0.959 (0.865–1.064); 0.441 0.990 (0.901–1.066); 0.636
Case status
c 2.074 (1.174–3.665); 0.017 N/A 1.609 (0.917–2.823); 0.104
Unique mutations
Age
a 1.163 (1.016–1.331); 0.035 1.181 (1.019–1.369); 0.036 1.240 (1.097–1.401); 0.002
Pack-year
b 0.987 (0.929–1.048); 0.666 0.978 (0.905–1.058); 0.585 0.989 (0.945–1.034); 0.624
Case status 1.183 (0.834–1.678); 0.352 N/A 1.116–0.835–1.493); 0.462
Nonunique mutations
Age
a 1.325 (0.962–1.824); 0.093 1.449 (1.154–1.819); 0.035 1.394 (1.015–1.913); 0.045
Pack-year
b 0.960 (0.835–1.103); 0.567 0.948 (0.830–1.084); 0.443 0.975 (0.875–1.087); 0.654
Case status 2.645 (1.290–5.423); 0.012 N/A 1.924 (0.915–4.048); 0.091
aRate ratio for 10-year age interval (95% confidence interval); P-value GLM.
bRate ratio for 10-pack-year interval (95% confidence interval); P-value GLM.
cRate ratio for case
status (95% confidence interval); P-value GLM. Statistically significant values are indicated in bold.
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Figure 3 Distribution of insertion and deletion of repeat-unit mutations
among all 1058 observed mutations. Approximately 40% of all mutations
could be explained by a simple insertion of a single repeat-unit in one of the
germline alleles. Insertion mutations were more frequently observed than
deletion mutations (79 vs 21%). No obvious differences were seen
between cases and controls.
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shigher number of mutations classified as ‘other’ compared to
controls (63 vs 18). However, 32 of these mutations were derived
from one case with closely spaced germline alleles that did not
allow us to distinguish between a  1o rþ1 repeat unit mutation
and hence were scored as ‘other’ mutations.
DISCUSSION
Cancers of the upper aerodigestive tract are one of the most
common cancers, but despite recent advances in genomics and
proteomics, there are only a limited number of biomarkers for
individual cancer risk. The accessibility of the oral mucosa allows
noninvasive sampling of cells exposed to environmental carcino-
gens. The study of genetic changes in these exposed cells may
elucidate mechanisms of carcinogenesis or identify candidate
biomarkers to determine risk of upper-airway cancers. Our study
is the first to investigate a possible use of a highly unstable
tetranucleotide marker in relation to age, smoking and HNSCC
using small-pool PCR on cells obtained by mouth rinse. We
observed a highly significant correlation of mutation frequencies
with the subject’s age, a correlation that was stable in several of the
markers and subject subgroups studied. These results are in
agreement with the elegant study by Coolbaugh-Murphy et al
(Coolbaugh-Murphy et al, 2005) where levels of microsatellite
mutations measured in blood lymphocytes also correlated with
age. Apart from a difference in target cells, these authors used a
different panel of microsatellite markers that included 1 mono-, 4
di- and 1 trinucleotide markers, but not any tetranucleotide
repeats. However, in our experience mononucleotide repeats, such
as BAT26 and BAT25, are very difficult to score for mutations due
to slippage artefacts during PCR, which renders these markers less
sensitive for true mutations. The same problem, although less
pronounced, also occurs when testing dinucleotide markers. An
additional problem associated with some microsatellite markers is
that of allelic dropout, where amplification reactions do not yield
any DNA products. Allelic drop-out may be due to high levels of
recombination resulting in deletion of the marker, variant
sequences around the marker that disrupt PCR amplification or
other causes. We previously found that the tetranucleotide
markers CSF1R-CITT and D21S1245 had high levels of nonampli-
fying alleles and similarly Coolbaugh-Murphy et al (2005) reported
this phenomenon for the dinucleotide marker D17S250. In the
current study, we did not observe any allelic dropouts when
determining germline allelic patterns. In terms of methodology,
our strategy allows small-pool PCR using a single-tube PCR setup,
facilitated by time-release PCR (Slebos et al, 2004b), that is
amendable to robotic automation. This setup reduces sample
handling and thus the risk of PCR contamination.
In previous studies, 25–50% of HNSCCs showed abnormalities in
D7S1482 (Coulet et al, 2000; Temam et al, 2005). In one of these
studies, the majority of the mutations observed were insertion
mutations (Coulet et al, 2000). In addition, D7S1482 has highest level
of mutations among all EMAST markers (five of 18) HNSCC and five
of 47 NSCLC, again, mostly by insertion mutations (Xu et al, 2001).
S i n c ew eh a v et oa s s u m et h ea b s e n c eo fs e l e c t i o np r e s s u r eo nt h i s
noncoding microsatellite, these data suggest that high levels of
mutations in precancerous cells become fixed during clonal
outgrowth of a mutant cell (field cancerisation) (Tabor et al, 2001).
Recently, several studies on the mechanisms that underlie
differences in mutation rates between markers and the association
with aging were reported. For example, the tetranucleotide marker
MycL1 was found to be more stable than other microsatellites in
MMR-negative cells, but more unstable in MMR-positive cells
(Hatch and Farber, 2004). Kovtun et al (2007) demonstrated age-
dependent expansion of a human Huntington’s disease-related
trinucleotide in transgenic mice). The levels of expansion were
greatly increased in double-transgenic mice that lacked a single
base-excision repair enzyme, 7,8-dihydro-8-oxoguanine-DNA gly-
cosylase (OGG1), indicating the important role of oxidative
damage in the expansion process. This study confirms and
expands our knowledge that oxidative DNA damage can lead to
microsatellite mutations (Jackson et al, 1998; Zienolddiny et al,
2000; Slebos et al, 2002). Other types of DNA damage, such as
those caused by ionising radiation, chemotherapeutic drugs, or
exposure to cadmium (Slebos et al, 2002; Jin et al, 2003; Kendall
et al, 2004) may also lead to mutant microsatellite sequences. With
the large number of studies suggesting that DNA damage leads to
increased levels of microsatellite mutations it is unclear why we
failed to observe a clear relationship between microsatellite
mutations and smoking history in our study. This was not due
to lack of range of smoking exposures in our control group
(see Table 1). Some possible explanations might be that D7S1482
does not capture the effects of smoking exposure or that pack-year
is linked to age to the extent that, with a limited study size, we
lacked the power to detect an effect of smoking. Larger study sets
with additional markers are needed to address this issue.
Of interest, the distinction of unique vs nonunique mutations,
although not perfect, separated associations with aging and cancer
status. Unique mutations were most strongly associated with age,
while nonunique mutations were mostly associated with cancer
status. These observations fit the hypothesis that the effects of
aging are random and are not associated with outgrowth of
particular cellular clones, while cancer patients are suffering from
the effects of field cancerisation and that nonunique mutation
frequency is capable of detecting at least some features of this
process. Thus, HNSCC patients might harbour higher levels of
clonal cell populations of D7S1482-mutant, but otherwise normal
cells, than comparable controls. Further studies will be needed to
prove such a relationship and if it may be used to assess cancer
risk in general. Such studies will benefit from the use of additional
hypermutable markers with reported high mutation levels, such as
MycL1, DXS981 or UT5307.
Although our study illustrates the power of single-molecule
analysis and confirms the essential role of aging in the accumulation
of DNA damage, several limitations exist to firmly establish that an
age-adjusted increase in microsatellite mutations is related to
increased cancer risk. Most important is that, at least for the case of
oral cavity carcinoma, the sampling site was also the site of a
previous carcinoma. However, all patients were followed for a
median time of 29 months after therapy to confirm the absence of
recurrence and to assure that no cancer cells were present at the
time of sampling. Another limitation is that a majority of HNSCC
patients were treated with chemotherapy and/or radiation and such
treatments may have confounded our findings. We therefore
performed a subanalysis with patients whose only treatment was
surgery and observed more significant effects than with the full set
of cases. Another limitation of our study is that although we were
able to match the large majority of cases and controls by age, sex
and smoking histories, the demographics of HNSCC patients is
greatly biased towards elderly males. The distribution of age
differences was balanced between the cases and controls, but our
study included more male smokers in the HNSCC case group than
in the control group. In univariate analyses, females were less likely
to demonstrate microsatellite mutations but since sex (and race)
was not included in our initial hypothesis and to avoid over-
matching our statistical model these two parameters were not
included in the analysis. Future studies will need to be powered
sufficiently to allow the inclusion of these, and other, variables.
A limitation of SP-PCR is that individual differences in the
position of the germline allele sizes may lead to differences in the
capability to detect mutations. For instance, in an individual with
two closely spaced allele sizes that are only one repeat unit apart it
is impossible to distinguish between the normally-sized larger
allele and a mutant allele derived from the smaller allele by
insertion of a single repeat unit. Our data predict that
Microsatellite mutations in buccal cells in HNSCC
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single deletion) may be missed in such cases. More sophisticated
statistical models may be capable of modeling the likelihood of
these types of situations. Of the 56 subjects in our study, nine
(16%) had D7S1482 allele sizes that were a single repeat unit apart
but confounding is unlikely since they did not cluster in any
specific group (five of 25 cases and six of 31 controls had closely
spaced alleles). Our study was limited to the hypermutable marker
D7S1482, which has one of the highest levels of mutations in upper
aerodigestive tract cancers (Ahrendt et al, 2000; Xu et al, 2001) and
the addition of newly identified hypermutable markers will
increase the number of possible mutant alleles that can be scored.
For our study, we used DNAs that were isolated from cells
collected through mouth rinse. Such sampling is noninvasive, can
be done repeatedly and requires no special equipment. Unlike
scraping or brushing of the oral cavity, mouth rinses are not
restricted to specific sites of the oral cavity. Thus, in a subject with
field cancerisation, mouth rinses may be more likely to sample
multiple clonal cell populations that may be located at different
subsites of the oral cavity. On the other hand, cells obtained from
mouth rinse may already have gone through terminal differentia-
tion with the associated degradation in DNA quality. It has also
been reported that cells obtained by mouth rinse contain
approximately 50% leukocytes, which may dilute the observed
mutation levels. However, it was also reported that blood cells
harbour many of the mutations we observed in cells obtained by
mouth rinse (Osswald et al, 2003; Coolbaugh-Murphy et al, 2005).
Future studies will be needed to establish differences between the
various sampling techniques.
In conclusion, we describe a novel assay in clinical specimens
based on direct amplification of single mutant alleles by SP-PCR.
We demonstrated a strong correlation between microsatellite
mutations and age and provide the first evidence that micro-
satellite mutations may be increased in non-cancerous cells
obtained from oral rinses of HNSCC patients. Using this assay
will open new avenues for the direct analysis of somatic mutational
load in exposed cells obtained from easily accessible clinical
specimens. These studies will be aided by the identification of
additional hypermutable microsatellite markers and further
automation of SP-PCR.
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